Sun Pharma Shares Crash as SEBI Plans to Reopen Insider Trading Case

Sun Pharmaceutical, its managing director Dilip Shanghvi and nine othes settled an insider trading probe on payment of Rs 18 lakh towards settlement charges.

from Top Business News- News18.com https://ift.tt/2EaLLVQ

• Tweet
• Share
• Share
• Share
• Share